• Company
• Gilead on its way to introduce HCV drug Epclusa in Korea
• by Eo, Yun-Ho Feb 23, 2021 06:11am

• Company
• Competition between Soliris & Enspryng is predicted in Korea
• by Eo, Yun-Ho Feb 23, 2021 06:11am

• Policy
• Antidiabetic drug GLP-1 RA to be recommended for NASH
• by Lee, in-bok Feb 23, 2021 06:11am

• Policy
• Weighted average price of α-GPC, ₩512
• by Lee, Hye-Kyung Feb 22, 2021 06:18am

• Company
• Dupixent to treat pediatric patients with atopic dermatitis
• by Eo, Yun-Ho Feb 22, 2021 06:17am

• InterView
• Genexine Licenses out immuno-cancer Drug Technology
• by Kim, Jin-Gu Feb 22, 2021 06:17am

• Policy
• Central Committee conflicted over Rekirona limits use
• by Lee, Tak-Sun Feb 22, 2021 06:17am

• Policy
• Ninlaro for multiple myeloma & Lutathera are listed
• by Lee, Hye-Kyung Feb 22, 2021 06:17am

• Policy
• AstraZeneca's vaccine, lot release for 780,000 people
• by Lee, Tak-Sun Feb 22, 2021 06:17am

• Company
• Talks on expanding coverage on Tecentriq to start soon
• by Eo, Yun-Ho Feb 19, 2021 06:17am